ASN helps craft bill aimed at instituting cost-neutrality for as many living donors as possible.
ASN celebrates legislation introduced on Wednesday, December 5, that would substantially bolster and expand support for living donors through an existing government program, commonly known as the National Living Donor Assistance Center.
The bipartisan bill—introduced by Congressional Kidney Caucus co-chairs Rep. Suzan DelBene and Rep. Larry Bucshon, MD, as well as kidney champions Rep. Carole Miller and Rep. Kim Schrier, MD—would make substantial inroads to achieving ASN’s goal of cost-neutrality for all living donors.
In summary, the bill would:
Together, these changes will strengthen the program, allow Congressional appropriators to allocate more funds to the program than statute currently permits, and enable more Americans to consider donation with the removal of financial impediments.
“In 2019, ASN celebrated the ambitious goals set by the Advancing American Kidney Health Initiative Executive Order, particularly having 80 percent of incident patients with kidney failure accessing to transplantation (or home dialysis) by 2025,” observed Roslyn B. Mannon, MD, FASN, transplant nephrologist and chair of the ASN Policy and Advocacy Committee. “Yet today, on the cusp of 2025, we have not achieved that milestone, and the annual number of living kidney donors has remained relatively flat for years, at approximately just under 6,000. I am hopeful that the expanded support this bill provides living donors will allow us to grow that number and enable meaningful progress towards achievement of that goal.”
Dr. Mannon also noted that one section of the bill directly builds upon pivotal progress made as part of the Executive Order, which expanded eligibility for the program to 350% of the poverty level.
ASN worked closely with lead sponsoring Congressional offices in crafting the legislation, reflective of cost-neutrality for living donors as one of the society’s top policy objectives.
“We are fortunate to have voices in Congress who are deeply committed to improving kidney and transplant care—as well as collaboration with the kidney and transplant community in shaping policies that help us all advance that shared objective,” said ASN Health Policy Scholar-in-Residence Suzanne Watnick, MD, FASN. “I anticipate this bill will be a top legislative priority for ASN in the 119th Congress and look forward to building bipartisan support for this crucial legislation.”